Gene · 6196
Papers2,567
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,567
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing SHP2-based combination therapy for KRAS-amplified cancer. | JCI Insight | 2023 | 36752207 | PubTator, text mining | PubMed |
| Integrative taxonomy reveals new, widely distributed tardigrade species of the genus Paramacrobiotus (Eutardigrada: Macrobiotidae). | Sci Rep | 2023 | 36750641 | PubTator, text mining | PubMed |
| ncRNAs mediated RPS6KA2 inhibits ovarian cancer proliferation via p38/MAPK signaling pathway. | Front Oncol | 2023 | 36741009 | PubTator, text mining | PubMed |
| Molecular mechanisms of microRNA-216a during tumor progression. | Cancer Cell Int | 2023 | 36740668 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
Next-generation sequencing shows the genomic features of ovarian clear cell cancer and compares the genetic architectures of high-grade serous ovarian cancer and clear cell carcinoma in ovarian and endometrial tissues. | PeerJ | 2023 | 36721777 | PubTator, text mining | PubMed |
| Mechanistic model of MAPK signaling reveals how allostery and rewiring contribute to drug resistance. | Mol Syst Biol | 2023 | 36700386 | PubTator, text mining | PubMed |
| Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma. | Biomedicines | 2023 | 36672689 | PubTator, text mining | PubMed |
| Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis. | Cancers (Basel) | 2023 | 36672479 | PubTator, text mining | PubMed |
| Claspin-Dependent and -Independent Chk1 Activation by a Panel of Biological Stresses. | Biomolecules | 2023 | 36671510 | PubTator, text mining | PubMed |
| Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition. | PLoS Pathog | 2023 | 36656913 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Proteomics separates adult-type diffuse high-grade gliomas in metabolic subgroups independent of 1p/19q codeletion and across IDH mutational status. | Cell Rep Med | 2023 | 36584682 | PubTator, text mining | PubMed |
| Long-term Temporal Stability of Peripheral Blood DNA Methylation Profiles in Patients With Inflammatory Bowel Disease. | Cell Mol Gastroenterol Hepatol | 2023 | 36581079 | PubTator, text mining | PubMed |
| Automated Image Analysis Reveals Different Localization of Synaptic Gephyrin C4 Splice Variants. | eNeuro | 2023 | 36543537 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics. | Semin Cancer Biol | 2023 | 36521737 | PubTator, text mining | PubMed |
| Probing prenatal bisphenol exposures and tissue-specific DNA methylation responses in cord blood, cord tissue, and placenta. | Reprod Toxicol | 2023 | 36473650 | PubTator, text mining | PubMed |
| Systematic identification of biochemical networks in cancer cells by functional pathway inference analysis. | Bioinformatics | 2023 | 36448701 | PubTator, text mining | PubMed |
| Design and biological characterization of a series of dual mechanism ERK1/2 inhibitors with a Triazolopyridinone core. | Chem Biol Drug Des | 2023 | 36434749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6196/papers?page=16